

Instance: composition-en-eb144117bf1832a81a0b81022c43f19d
InstanceOf: CompositionUvEpi
Title: "Composition for granupas Package Leaflet"
Description:  "Composition for granupas Package Leaflet"
Usage: #inline

* identifier.system = ""

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mock)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - granupas"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet </p>
<ol>
<li>What GRANUPAS is and what it is used for </li>
<li>What you need to know before you take GRANUPAS </li>
<li>How to take GRANUPAS </li>
<li>Possible side effects </li>
<li>How to store GRANUPAS </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What granupas is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What granupas is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>GRANUPAS contains para-aminosalicylic acid which is used in adults and children aged 28 days and 
older to treat resistant tuberculosis in combination with other medicines, in cases of resistance or 
intolerability with other treatments. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take granupas"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take granupas"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take GRANUPAS 
* if you are allergic to para-aminosalicylic acid or any of the other ingredients of this 
medicine (listed in section 6). 
* if you have severe kidney disease. 
If you are not sure, talk to your doctor or pharmacist before taking GRANUPAS. </p>
<p>Warnings and precautions 
Talk to your doctor or pharmacist before taking GRANUPAS 
* if you have liver problems or mild or moderate kidney disease 
* if you have a stomach ulcer 
* if you are infected with HIV </p>
<p>Children<br />
Use of GRANUPAS is not recommended in newborn babies (under 28 days of age). </p>
<p>Other medicines and GRANUPAS 
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other 
medicines. </p>
<p>It is especially important to tell your doctor if you are taking any of the following: 
* Antituberculosis medicines or ethionamide (other treatments against tuberculosis) 
* Vitamin B* Digoxin (for heart disease) 
* Diphenylhydramine (for allergic reactions) 
* Tenofovir (for HIV/ hepatitis B infections) </p>
<p>Pregnancy and breast-feeding 
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask 
your doctor or pharmacist for advice before taking this medicine. 
GRANUPAS is not recommended during pregnancy and should only be used if advised by your 
physician. 
Do not breastfeed whilst taking GRANUPAS. This is because small amounts of the medicine can 
pass into mother s milk. </p>
<p>Driving and using machines 
GRANUPAS is unlikely to affect your ability to drive any vehicle and use machines. 
In case it does, please report it to your doctor or pharmacist. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take granupas"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take granupas"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist 
if you are not sure. </p>
<p>Adults 
The recommended dose for adults is 1 sachet three times a day, with a schedule of 1 sachet every 
8 hours. Your physician may need to start with a lower dose to prevent possible side effects. 
Do not take more than 3 sachets per day. Treatment is usually given for two years (24 months). </p>
<ul>
<li>Add the contents of the sachet to a drink of tomato or orange juice. </li>
<li>Drink straight away </li>
<li>If some granules are left in the glass, add some more juice and drink straight away. </li>
</ul>
<p>Use in infants, children and adolescents 
The dose in infants, children and adolescents will be calculated by your doctor based on the patient s 
body weight. The recommended total dose per day is 150 mg for each kg of body weight. This daily 
amount is divided into two doses spread out through the day. </p>
<ul>
<li>Use the spoon that comes with the medicine to measure the dose. </li>
<li>To measure the dose: * Lines on the spoon indicate the amount (in milligrams of para-aminosalicylic acid). 
Take the correct amount as prescribed by your doctor. * Put granules directly into the spoon. * Tap the spoon once on a table to give a horizontal level of granules and 
continue filling if necessary. </li>
<li>Sprinkle the granules onto apple sauce or yogurt. </li>
<li>Make your child eat it straight away. </li>
</ul>
<p>Taking this medicine 
* Do not crush or chew the granules. Swallow the granules whole. It is important that you do not 
dissolve, crush or chew the granules as they may not absorb properly and may cause stomach 
ache or bleeding. 
* Do not use the sachet if it is swollen or the granules have lost their light brown colour. 
* You may notice granules appearing in your stools; this is normal. </p>
<p>If you take more GRANUPAS than you should 
Speak to a doctor or pharmacist. </p>
<p>If you forget to take a dose of GRANUPAS 
Do not take a double dose to make up for a forgotten dose. Wait until the next dose is due, then take 
your normal dose. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>During the first 3 months of your treatment with GRANUPAS, you must be attentive to any sign of 
allergic reaction (for example skin eruption, itchy red spots on the skin, itching, rash, watery or itchy 
eyes or stuffy nose) or hepatitis (for example fever, fatigue, dark urine, pale stool, abdominal pain, 
yellow skin and eyes). If you experience any of these symptoms, you must contact to your doctor 
immediately. </p>
<p>Common side effects (may affect more than 1 in 100 people):<br />
<em> giddiness,<br />
</em> stomach ache (abdominal pain),<br />
<em> vomiting,<br />
</em> nausea,<br />
<em> bloating,<br />
</em> diarrhoea,<br />
<em> soft stools,<br />
</em> skin redness or rash,<br />
* disturbance of gait and equilibrium. </p>
<p>Uncommon side effects (may affect more than 1 in 1,000 people):<br />
* loss of appetite (anorexia). </p>
<p>Rare side effects (may affect more than 1 in 10,000 people):<br />
<em> thyroid gland problems</em>,<br />
<em> reduced ability to absorb nutrients from food ulcer,<br />
</em> bleeding in the gut,<br />
<em> yellowing of skin or eyes (jaundice),<br />
</em> metallic taste,<br />
* itchy rash. </p>
<p>(*) in subjects also infected with HIV thyroid gland problems and specifically underactive thyroid or 
low levels of thyroid hormones, are a very common side effect that may affect more than 1 in people. Regular monitoring of the thyroid function is indicated for all people living with HIV. </p>
<p>Very rare side effects (may affect less than 1 in 10,000 people):<br />
<em> reduction in blood platelets, 
* red spots on the skin,<br />
</em> reduction in numbers of white blood cells,<br />
<em> reduction in numbers of red blood cells,<br />
</em> reduction of the ability of red blood cells to release oxygen<br />
<em> low levels of blood sugar,<br />
</em> tendon pain,<br />
<em> headache,<br />
</em> visual abnormalities,<br />
* nerve damage in the hands and feet,  </p>
<ul>
<li>dizziness,  </li>
<li>crystals in urine. </li>
<li>prolonged bleeding time, </li>
<li>destruction of liver cells  </li>
<li>elevated liver enzymes,  </li>
<li>weight loss.  </li>
</ul>
<p>Not known side effects (frequency cannot be estimated from the available data):<br />
* Hepatitis. </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety of 
this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store granupas"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store granupas"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the carton and sachet after EXP. The 
expiry date refers to the last day of the month. </p>
<p>Do not store above 25 C. The sachets can be stored below 25 C up to 24 hours after opening. </p>
<p>Do not use this medicine if you notice the sachets are swollen or if the granules are dark brown or 
purple. </p>
<p>Do not throw away any medicines via wastewater or household waste.<br />
Ask your pharmacist how to throw away medicines you no longer use. These measures will help 
protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What GRANUPAS contains<br />
The active substance is para-aminosalicylic acid. 
Each sachet of gastro-resistant granules contains 4 g of para-aminosalicylic acid. 
The other ingredients are silica, colloidal hydrated, dibutyl sebacate, methacrylic acid   ethyl acrylate 
copolymer (1:1) dispersion 30 per cent, hypromellose, cellulose, microcrystalline, talc. </p>
<p>What GRANUPAS looks like and contents of the pack 
This medicine is presented as light brown gastro-resistant granules in sachets.<br />
Each box contains 30 sachets. A calibrated measuring spoon is provided. </p>
<p>Marketing Authorisation Holder 
Eurocept International BV 
Trapgans 5 
1244 RL Ankeveen 
The Netherlands </p>
<p>Manufacturer </p>
<p>Eurocept International BV 
Trapgans 5 </p>
<p>1244 RL Ankeveen 
The Netherlands </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder: </p>
<p>Belgi /Belgique/Belgien 
Lucane Pharma 
T l/Tel: + 33 153 868 info@lucanepharma.com 
Lietuva<br />
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com </p>
<p>Lucane Pharma 
Te .: + 33 153 868 info@lucanepharma.com 
Luxembourg/Luxemburg 
Lucane Pharma 
T l/Tel: + 33 153 868 info@lucanepharma.com 
 esk  republika 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Magyarorsz g 
Lucane Pharma 
                 Tel.: + 33 153 868 info@lucanepharma.com 
Danmark 
Lucane Pharma 
Tlf: + 33 153 868 info@lucanepharma.com 
Malta 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Deutschland 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Nederland 
Eurocept International BV 
Tel: +31 35 528 39 info@euroceptpharma.com 
Eesti 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Norge 
Lucane Pharma 
Tlf: + 33 153 868 info@lucanepharma.com </p>
<p>Lucane Pharma 
 : + 33 153 868 info@lucanepharma.com 
 sterreich 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Espa a 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com </p>
<p>Polska 
                  Lucane Pharma 
Tel.: + 33 153 868 info@lucanepharma.com 
France 
Lucane Pharma 
T l: + 33 153 868 info@lucanepharma.com 
Portugal 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Hrvatska 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Rom nia 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com </p>
<p>Ireland 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Slovenija 
                  Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
 sland 
Lucane Pharma 
S mi: + 33 153 868 info@lucanepharma.com 
Slovensk  republika<br />
                      Lucane Pharma 
    Tel: + 33 153 868 info@lucanepharma.com 
Italia 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Suomi/Finland 
Lucane Pharma 
Puh/Tel: + 33 153 868 info@lucanepharma.com </p>
<p>Lucane Pharma 
 : + 33 153 868 info@lucanepharma.com 
Sverige 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Latvija 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
United Kingdom 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com </p>
<p>This leaflet was last revised in  </p>
<p>Other sources of information </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      

